A new platform for studying neuroinflammatory diseases, utilizing advanced 3D bioprinting technology has been developed.

Systemic Bio™, a 3D Systems company (NYSE: DDD), has been named the winner of the prestigious SLAS 2025 Innovation Award. This award recognizes groundbreaking technological advancements poised to ...

Tissue engineering utilizes 3D printing and bioink to grow human cells on scaffolds, creating replacements for damaged ...

Discover how a revolutionary 3D Blood-Brain Barrier model advances the understanding of neurodegenerative diseases and drug ...

This study presents a kombucha-derived bioink and digital biopen, advancing in vivo tissue engineering with efficient, ...

In a new breakthrough, researchers at Seoul National University of Science and Technology (SEOULTECH) have developed a novel ...

D Systems is investing in bioprinting and custom implants. Click here to read why investors with high-risk tolerance may ...

Sixty percent of consumers in India are willing to consume cultivated meat and 46 percent would pay a premium for it, ...

Our goal is to integrate genome editing with state-of-the-art 3D bioprinting modalities and demonstrate the functional advantage of genome-edited inflammation-resistant 3D bioprinted constructs in ...

SEOULTECH researchers develop Kombucha SCOBY bioink - enabling the creation of multilayer, self-standing structures with high resolution.

Researchers in the University of Galway have made a breakthrough in 3D bioprinting of human heart tissueThis is a technique ...

Learn about Jennifer Lewis, Harvard Professor and recipient of the 2025 James Prize. Explore her groundbreaking research in ...